Poly(Anhydride) Nanoparticles Act as Active Th1 Adjuvants through Toll-Like Receptor Exploitation

• Published in: Clinical and Vaccine Immunology Vol. 17; no. 9; pp. 1356 - 1362
• Main Authors: Tamayo, I., Irache, J. M., Mansilla, C., Ochoa-Repáraz, J., Lasarte, J. J., Gamazo, C.
• Format: Journal Article
• Language: English
• Published: United States American Society for Microbiology 01-09-2010; American Society for Microbiology (ASM)
• Subjects: Adjuvants, Immunologic - pharmacology; Animals; B7-2 Antigen - biosynthesis; CD8-Positive T-Lymphocytes - immunology; Dendritic Cells - immunology; Gene Expression; Intercellular Adhesion Molecule-1 - biosynthesis; Interferon-gamma - secretion; Interleukin-12 - secretion; Maleates - pharmacology; Mice; Mice, Inbred BALB C; Nanoparticles - administration & dosage; Polyethylenes - pharmacology; Salmonella enterica; Salmonella enteritidis - immunology; Salmonella enteritidis - pathogenicity; Survival Analysis; Th1 Cells - immunology; Toll-Like Receptors - agonists; Toll-Like Receptors - immunology; Vaccine Research
• ISSN: 1556-6811; 1556-679X; 1556-679X
• DOI: 10.1128/CVI.00164-10

Classifications
Services
CVI
Citing Articles
Google Scholar
PubMed
Related Content
Social Bookmarking
CiteULike
Delicious
Digg
Facebook
Google+
Mendeley
Reddit
StumbleUpon
Twitter
current issue
CVI
About
CVI
Subscribers
Authors
Reviewers
Advertisers
Inquiries from the Press
Permissions & Commercial Reprints
ASM Journals Public Access Policy
CVI
RSS Feeds
1752 N Street N.W. • Washington DC 20036
202.737.3600 • 202.942.9355 fax • [e-mail]
Print ISSN:
1556-6811
Online ISSN:
1556-679X
Copyright © 2014
by the
American Society for Microbiology.  
For an alternate route to
CVI
.asm.org, visit:
CVI